PAVAN, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 74
EU - Europa 27
AS - Asia 24
Totale 125
Nazione #
US - Stati Uniti d'America 74
IT - Italia 21
SG - Singapore 16
CN - Cina 6
FI - Finlandia 2
SE - Svezia 2
FR - Francia 1
GR - Grecia 1
IL - Israele 1
IN - India 1
Totale 125
Città #
Singapore 13
Fairfield 11
Ashburn 9
Chandler 9
Santa Clara 7
Wilmington 6
Houston 5
Padova 5
Pignone 4
Woodbridge 4
Turin 3
Cambridge 2
Helsinki 2
Seattle 2
Athens 1
Bari 1
Castelfranco Veneto 1
Fort Worth 1
Los Angeles 1
Medford 1
Princeton 1
Prineville 1
Pune 1
Redwood City 1
Roxbury 1
San Diego 1
Springfield 1
Tel Aviv 1
Totale 96
Nome #
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer 91
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis 12
Assessment of chromosomal rearrangements helps to differentiate multiple lung primary cancers from metastases 11
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis 7
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironment 7
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer 3
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World 3
Totale 134
Categoria #
all - tutte 619
article - articoli 619
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.238


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 0 0 6
2020/202131 0 4 2 3 4 2 2 6 1 4 0 3
2021/202222 2 3 1 5 2 1 0 5 0 0 0 3
2022/202312 3 2 0 3 1 1 0 0 0 1 1 0
2023/202417 0 3 1 0 0 2 0 3 0 5 0 3
2024/202546 1 17 15 13 0 0 0 0 0 0 0 0
Totale 134